Clinical Trial Update: Prevention of Serious Adverse Events Following Angiography [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prevention of serious adverse events following angiography has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Kidney Disease
• Kidney Injury

Snippet

Sponsor: VA Office of Research and Development | Conditions: Acute Renal Failure, Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-11-09